New procedures for Brazilian pharmaceutical patents
Managing Intellectual Property
Brazil's National Health Surveillance Agency (ANVISA) has issued a new resolution requiring that all patent applications relating to pharmaceutical products and processes must be approved by the agency prior to allowance...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.